Cellibre, founded in 2019, is a leading player in the Biotechnology, Manufacturing, and Sustainability sectors headquartered in the United States. Their slogan, "We turn cells into specialized, sustainable factories for the manufacture of globally significant products at scale," outlines their innovative edge in converting cells into production engines for key global products.
Using an organism-agnostic technology, Cellibre has demonstrated success in multiple fields from energy to medicine. This ability to pivot across diverse sectors positions them uniquely in the market.
The organization is affiliated with notable groups such as BioMade and the Defense Industrial Base Consortium (DIBC), pointing to robust industry connections.
The company's recent interest from investors is evident with a Venture - Series Unknown investment made on 08 October 2024, although specific investors were not disclosed. This investment underscores confidence in their technology and growth potential.